Florida Health Daily
SEE OTHER BRANDS

Your best source on healthcare and wellness news from Florida

Florida Health Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.

Press releases published on April 10, 2025

(OTC: CATV) Reports Nearly $500K in Q4 Revenue, eliminates $830K in Debt, and Appoints CEO to Lead Bold Transformation

(OTC: CATV) Reports Nearly $500K in Q4 Revenue, eliminates $830K in Debt, and Appoints CEO to Lead Bold Transformation

Susan Ward joins as CEO to spearhead Opus Holdings’ into a high-growth business incubator model after pivotal year of restructuring and Share dilution reduction MIAMI, FL, UNITED STATES, April 10, 2025 /⁨EINPresswire.com⁩/ -- Opus Holdings, Inc. (OTC: …

Brisk MD Announces Comprehensive Behavioral Health and Opioid Addiction Treatment Programs

Brisk MD Announces Comprehensive Behavioral Health and Opioid Addiction Treatment Programs

Woodlyn, PA – Brisk MD a leading provider of mental health and addiction treatment services. TAMPA, FL, UNITED STATES, April 10, 2025 /⁨EINPresswire.com⁩/ -- Brisk MD a leading provider of mental health and addiction treatment services, is proud to …

At A Safe Haven for Newborns Everyone is Helped

At A Safe Haven for Newborns Everyone is Helped

Every Call is Confidential, No Questions Asked or Judged MIAMI, FL, UNITED STATES, April 10, 2025 /⁨EINPresswire.com⁩/ -- The Gloria M. Silverio Foundation, 501(c)(3), d/b/a A Safe Haven for Newborns, is a lifeline for teens and women who unexpectedly …

The Box Doc in Davie, FL Introduces Focal Shockwave Therapy for Accelerated Recovery and Lasting Pain Relief

The Box Doc in Davie, FL Introduces Focal Shockwave Therapy for Accelerated Recovery and Lasting Pain Relief

The Box Doc adds FDA-registered PiezoWave2 Focal Shockwave Therapy to accelerate healing, relieve pain, and enhance mobility for physical therapy patients. DAVIE, FL, UNITED STATES, April 10, 2025 /⁨EINPresswire.com⁩/ -- The Box Doc, a leading physical …

CodaPet launches compassionate in-home pet euthanasia services to Jacksonville, FL, and surrounding areas.

CodaPet launches compassionate in-home pet euthanasia services to Jacksonville, FL, and surrounding areas.

The veterinarian-owned startup empowers a network of veterinarians who provide in-home euthanasia to ease the passing of pets at home, surrounded by loved ones. JACKSONVILLE, FL, UNITED STATES, April 10, 2025 /⁨EINPresswire.com⁩/ -- CodaPet has officially …

Immuron Travelan® highest sales in history

Immuron Travelan® highest sales in history

Sales Highlights (unaudited): Global Immuron exceeds AUD$5 million in sales in a fiscal year - highest sales in history March 2025 Quarter AUD$1.3 million up 2% on prior year March 2025 Year to Date AUD$5.3 million up 46% on prior year Australia March 2025 …

argenx Announces FDA Approval of VYVGART Hytrulo Prefilled Syringe for Self-Injection in Generalized Myasthenia Gravis and Chronic Inflammatory Demyelinating Polyneuropathy

argenx Announces FDA Approval of VYVGART Hytrulo Prefilled Syringe for Self-Injection in Generalized Myasthenia Gravis and Chronic Inflammatory Demyelinating Polyneuropathy

VYVGART, the first-in-class FcRn blocker, now offers three administration options, including self-injection with a prefilled syringe Self-injection provides gMG and CIDP patients with flexibility for when and where to receive treatment – at home, while ‘on …

Crinetics Pharmaceuticals Announces April 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Crinetics Pharmaceuticals Announces April 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, April 10, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on April 10, 2025, the Compensation Committee of the Board of Directors granted non-qualified stock option awards to purchase an aggregate of …

Passing of former Chief Executive Officer, Dr. Loressa Cole

Passing of former Chief Executive Officer, Dr. Loressa Cole

SILVER SPRING, MD, April 10, 2025 (GLOBE NEWSWIRE) -- It is with profound sadness that we share the passing of our former Chief Executive Officer, Loressa Cole, DNP, MBA, RN, NEA-BC, FAAN, FACHE.  Loressa was a beloved member of the American Nurses …

Harvard Bioscience Announces CFO Transition

Harvard Bioscience Announces CFO Transition

HOLLISTON, Mass., April 10, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced the resignation of Jennifer Cote, the Company’s Chief Financial Officer and Treasurer. Ms. Cote’s resignation will be effective …

Odylia Therapeutics drives commitment to rare disease drug development through Rare Disease Day event

Odylia Therapeutics drives commitment to rare disease drug development through Rare Disease Day event

BOSTON, MA, April 10, 2025 (GLOBE NEWSWIRE) -- Odylia Therapeutics (Odylia) a nonprofit biotechnology company dedicated to expediting drug development for rare diseases, hosted a Rare Disease Day event to foster conversations about new funding models and …

Arcutis Announces Chief Financial Officer Transition

Arcutis Announces Chief Financial Officer Transition

WESTLAKE VILLAGE, Calif., April 10, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced that David Topper, …

BioClick – an enzyme engineering game-changer, launched by eXoZymes and supported by a $300K NIH grant

BioClick – an enzyme engineering game-changer, launched by eXoZymes and supported by a $300K NIH grant

Monrovia, CA, April 10, 2025 (GLOBE NEWSWIRE) -- Today, eXoZymes Inc. (NASDAQ: EXOZ) (“eXoZymes”) - a pioneer of AI-engineered enzymes that can transform sustainable feedstock into nutraceuticals, medicines, and other essential chemicals - announced its …

Venus Concept Announces Closing of $1.1 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules

Venus Concept Announces Closing of $1.1 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules

TORONTO, April 10, 2025 (GLOBE NEWSWIRE) --  Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced the closing of its previously announced registered direct offering priced at- …

Adaptive Biotechnologies to Report First Quarter 2025 Financial Results on May 1, 2025

Adaptive Biotechnologies to Report First Quarter 2025 Financial Results on May 1, 2025

SEATTLE, April 10, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease …

BrightSpring Health Services, Inc. to Announce First Quarter 2025 Financial Results on May 2, 2025

BrightSpring Health Services, Inc. to Announce First Quarter 2025 Financial Results on May 2, 2025

LOUISVILLE, Ky., April 10, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQ: BTSG) announced today that it plans to release its first quarter 2025 financial results on Friday, May 2, 2025, prior to the …

Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

DUBLIN, April 10, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on transforming medicines to transform lives, today announced that the Compensation Committee of Avadel’s Board of Directors approved the grant of non- …

Protara Therapeutics to Present Interim Analysis from the Phase 2 ADVANCED-2 Trial of TARA-002 in Patients with NMIBC at the American Urological Association Annual Meeting

Protara Therapeutics to Present Interim Analysis from the Phase 2 ADVANCED-2 Trial of TARA-002 in Patients with NMIBC at the American Urological Association Annual Meeting

NEW YORK, April 10, 2025 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced that two presentations and a panel …

Folia Health Expands Its Rare Renal Disease Research with a New C3G Study to Assess Real-World Disease Impact

Folia Health Expands Its Rare Renal Disease Research with a New C3G Study to Assess Real-World Disease Impact

BOSTON, April 10, 2025 (GLOBE NEWSWIRE) -- Folia Health launches enrollment for an innovative, at-home real-world evidence initiative for individuals with C3 glomerulopathy (C3G). Designed in partnership with C3G clinicians and patients, this study uses …

PROCEPT BioRobotics® Announces Investor Event at 2025 AUA Annual Meeting at the Aria Resort in Las Vegas

PROCEPT BioRobotics® Announces Investor Event at 2025 AUA Annual Meeting at the Aria Resort in Las Vegas

SAN JOSE, Calif., April 10, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company, whose mission is to revolutionize BPH treatment globally, announced today it will host an in-person investor …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service